Rein Therapeutics (RNTX) Debt Ratio (2018 - 2026)
Rein Therapeutics' (RNTX) Debt Ratio came in at 0.19 for Q1 2026.
Powered by 
Analysis
Rein Therapeutics (RNTX) Debt Ratio (2018 - 2026) Analysis & Trends
For FY2018, Rein Therapeutics' Debt Ratio stood at 0.18.
- The Q1 2026 figure stands as the lowest quarterly Debt Ratio since Q4 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 0.24 |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 0.52 |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 0.42 |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 0.31 |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 0.00 |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 0.60 |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 0.53 |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 0.31 |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | - |
| 10 | Rein Therapeutics | 53.00 Mn | 53.00 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 0.19 |
| Dec 31, 2018 | 0.18 |
| Sep 30, 2018 | 0.13 |
| Jun 30, 2018 | 0.08 |
API Access
Rein Therapeutics Debt Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=debt-ratio&ticker=RNTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "debt-ratio", "ticker": "RNTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=debt-ratio&ticker=RNTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();